Evidence map›Paper›PMID 33209115›Full record

ArticleEcancermedicalscience2020

Impact of the 8th edition of the AJCC TNM classification on gastric cancer prognosis-study of a western cohort.

Mariana Peyroteo, Pedro Carvalho Martins, Rita Canotilho, Ana Margarida Correia, Catarina Baía, Alexandre Sousa, Donzília Brito, José Flávio Videira, Lúcio Lara Santos, Abreu de Sousa

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mariana PeyroteoSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Pedro Carvalho MartinsSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Rita CanotilhoSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Ana Margarida CorreiaSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Catarina BaíaSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Alexandre SousaSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Donzília BritoSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
José Flávio VideiraSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Lúcio Lara SantosSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.
Abreu de SousaSurgical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe 8th edition of the American Joint Committee on Cancer (AJCC) TNM classification for gastric cancer introduced changes, mainly in stage III, with the incorporation of the pN3 sub-classification in the final staging group. The goal was to compare the 7th and 8th editions to evaluate the discriminative capacity of the new edition.

methodsThis study was a retrospective review of patients with gastric cancer treated with surgery in 2013 and 2014.

resultsWe analysed 310 patients, with a median age of 66 years and out of which 55.5% were male. The most commonly performed surgery was subtotal gastrectomy (

conclusionThe 8th edition of the AJCC TNM classification allows for a better prognostic refinement, namely in the new stage III groups after the stratification of lymph node disease in N3a and N3b. Factors that evaluate the biological behaviour of the disease remain excluded from this edition, such as extracapsular extension, which had a prognostic impact in our series.

Indexed as

AJCCeighth edition TNM classificationgastric cancerstaging

Identifiers

PMID33209115
PMCPMC7652425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.